Literature DB >> 9370523

Estimating xenobiotic half-lives in humans from rat data: influence of log P.

J G Sarver1, D White, P Erhardt, K Bachmann.   

Abstract

The nature of empirical allometric expressions relating dispositional and kinetic parameters for a given xenobiotic across multiple mammalian species is well known. It has also been demonstrated that a simple allometric relationship may be used to predict kinetic parameters for humans based merely on data for multiple xenobiotics from rats. We decided to explore reasons for the variance in the data arising from the latter method. We were particularly interested in learning whether any physicochemical characteristics of xenobiotics might account for outlying data points (i.e., poor prediction of human half-life from rat half-life). We have explored the influence of lipid solubility as reflected by a xenobiotic's log P value because adipose tissue comprises a significantly larger percentage of total body weight in humans than in rats. We used half-life data from the literature for 127 xenobiotics. A data subset of 102 xenobiotics for which we were able to find estimates of log P values, including several with extremely large log P values, was also analyzed. First and second order models, including and excluding log P, were compared. The simplest of these models can be recast as the familiar allometric relationship having the form Y = a(Xb). The remaining models can be seen as extensions of this relationship. Our results suggest that incorporation of log P into the prediction of xenobiotic half-life in humans from rat half-life data is important only for xenobiotics with extremely large log P values such as dioxins and polychlorinated biphenyls. Moreover, a second order model in logarithm of rat half-life accommodates all data points very well, without specifically accounting for log P values.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9370523      PMCID: PMC1470336          DOI: 10.1289/ehp.971051204

Source DB:  PubMed          Journal:  Environ Health Perspect        ISSN: 0091-6765            Impact factor:   9.031


  37 in total

1.  The concentration-dependent disposition and kinetics of inulin.

Authors:  L F Prescott; J A McAuslane; S Freestone
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

2.  Effect of chlorination on the distribution and excretion of polychlorinated biphenyls.

Authors:  H B Mathews; M W Anderson
Journal:  Drug Metab Dispos       Date:  1975 Sep-Oct       Impact factor: 3.922

3.  Interspecies extrapolation of pharmacokinetics.

Authors:  C C Travis; R K White; R C Ward
Journal:  J Theor Biol       Date:  1990-02-09       Impact factor: 2.691

4.  Ethylene glycol intoxication: evaluation of kinetics and crystalluria.

Authors:  D Jacobsen; T P Hewlett; R Webb; S T Brown; A T Ordinario; K E McMartin
Journal:  Am J Med       Date:  1988-01       Impact factor: 4.965

5.  Metabolites, pharmacodynamics, and pharmacokinetics of tamoxifen in rats and mice compared to the breast cancer patient.

Authors:  S P Robinson; S M Langan-Fahey; D A Johnson; V C Jordan
Journal:  Drug Metab Dispos       Date:  1991 Jan-Feb       Impact factor: 3.922

Review 6.  The toxicity of brominated and mixed-halogenated dibenzo-p-dioxins and dibenzofurans: an overview.

Authors:  L W Weber; H Greim
Journal:  J Toxicol Environ Health       Date:  1997-02-21

7.  In vivo and in vitro dermal penetration of 2,4,5,2',4',5'-hexachlorobiphenyl in young and adult rats.

Authors:  H L Fisher; P V Shah; M R Sumler; L L Hall
Journal:  Environ Res       Date:  1989-10       Impact factor: 6.498

8.  Effects of tenoxicam on renal function and the disposition of inulin and p-aminohippurate in healthy volunteers and patients with chronic renal failure.

Authors:  S Freestone; J A McAuslane; L F Prescott
Journal:  Br J Clin Pharmacol       Date:  1991-10       Impact factor: 4.335

Review 9.  Amiodarone. An overview of its pharmacological properties, and review of its therapeutic use in cardiac arrhythmias.

Authors:  J Gill; R C Heel; A Fitton
Journal:  Drugs       Date:  1992-01       Impact factor: 9.546

10.  The effect of increasing age on thiopental disposition and anesthetic requirement.

Authors:  T D Homer; D R Stanski
Journal:  Anesthesiology       Date:  1985-06       Impact factor: 7.892

View more
  12 in total

1.  Pharmacokinetics of cotinine in rats: a potential therapeutic agent for disorders of cognitive function.

Authors:  Pei Li; Wayne D Beck; Patrick M Callahan; Alvin V Terry; Michael G Bartlett
Journal:  Pharmacol Rep       Date:  2014-12-16       Impact factor: 3.024

2.  Estimating Margin of Exposure to Thyroid Peroxidase Inhibitors Using High-Throughput in vitro Data, High-Throughput Exposure Modeling, and Physiologically Based Pharmacokinetic/Pharmacodynamic Modeling.

Authors:  Jeremy A Leonard; Yu-Mei Tan; Mary Gilbert; Kristin Isaacs; Hisham El-Masri
Journal:  Toxicol Sci       Date:  2016-02-10       Impact factor: 4.849

3.  Towards a better prediction of peak concentration, volume of distribution and half-life after oral drug administration in man, using allometry.

Authors:  Vikash K Sinha; Karin Vaarties; Stefan S De Buck; Luca A Fenu; Marjoleen Nijsen; Ron A H J Gilissen; Wendy Sanderson; Kelly Van Uytsel; Eva Hoeben; Achiel Van Peer; Claire E Mackie; Johan W Smit
Journal:  Clin Pharmacokinet       Date:  2011-05       Impact factor: 6.447

4.  Effects of developmental exposure to polychlorinated biphenyls and/or polybrominated diphenyl ethers on cochlear function.

Authors:  Emily Poon; Brian E Powers; Ruth M McAlonan; Duncan C Ferguson; Susan L Schantz
Journal:  Toxicol Sci       Date:  2011-08-26       Impact factor: 4.849

5.  Evaluating the Impact of Uncertainties in Clearance and Exposure When Prioritizing Chemicals Screened in High-Throughput Assays.

Authors:  Jeremy A Leonard; Ashley Sobel Leonard; Daniel T Chang; Stephen Edwards; Jingtao Lu; Steven Scholle; Phillip Key; Maxwell Winter; Kristin Isaacs; Yu-Mei Tan
Journal:  Environ Sci Technol       Date:  2016-05-12       Impact factor: 9.028

6.  Toxicogenomic evaluation of long-term hepatic effects of TCDD in immature, ovariectomized C57BL/6 mice.

Authors:  Anna K Kopec; Darrell R Boverhof; Rance Nault; Jack R Harkema; Colleen Tashiro; Dave Potter; Bonnie Sharratt; Brock Chittim; Timothy R Zacharewski
Journal:  Toxicol Sci       Date:  2013-07-17       Impact factor: 4.849

7.  Allometric scaling of pharmacokinetic parameters in drug discovery: can human CL, Vss and t1/2 be predicted from in-vivo rat data?

Authors:  Gary W Caldwell; John A Masucci; Zhengyin Yan; William Hageman
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2004 Apr-Jun       Impact factor: 2.441

8.  Structural modulation of oxidative metabolism in design of improved benzothiophene selective estrogen receptor modulators.

Authors:  Zhihui Qin; Irida Kastrati; Rezene T Ashgodom; Daniel D Lantvit; Cassia R Overk; Yongsoo Choi; Richard B van Breemen; Judy L Bolton; Gregory R J Thatcher
Journal:  Drug Metab Dispos       Date:  2008-10-20       Impact factor: 3.922

9.  Quantitative structure-activity relationships (QSARs) within the cytochrome P450 system: QSARs describing substrate binding, inhibition and induction of P450s.

Authors:  David F V Lewis
Journal:  Inflammopharmacology       Date:  2003       Impact factor: 4.473

10.  The fate of inhaled (14)C-labeled PCB11 and its metabolites in vivo.

Authors:  Xin Hu; Andrea Adamcakova-Dodd; Peter S Thorne
Journal:  Environ Int       Date:  2013-11-22       Impact factor: 9.621

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.